Anaveon is a late stage preclinical biotech company focused on developing engineered antibodies that target central regulatory nodes of the immune system to treat autoimmune diseases
Anaveon is a late stage preclinical biotech company focused on developing engineered antibodies that target central regulatory nodes of the immune system to treat autoimmune diseases.